Medicamen Organics Limited, established in 1995, develops, manufactures, and distributes a wide array of pharmaceutical products including tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders. The company serves both government and private sectors, acting as a contract and third-party manufacturer. It has a strong presence in domestic markets and is expanding internationally, notably exporting directly to Burundi in 2023. Medicamen's products are distributed across India and several international regions such as Africa, CIS, and Southeast Asia through third-party distributors.
The company began trading pharmaceuticals for government departments in 1996 and expanded to manufacturing with its Haridwar unit in 2007, which received WHO/GMP certification. In 2010, Medicamen obtained licenses for producing food supplements. A joint venture in 2017 with a Danish company facilitated global export of iron products. Now, Medicamen is poised for further growth with an Initial Public Offering of 3.2 million fresh equity shares.
